
Veeva Systems (VEEV) Stock Forecast & Price Target
Veeva Systems (VEEV) Analyst Ratings
Bulls say
Veeva Systems is benefiting from rapid growth in the life sciences industry, as reflected in its strong subscription growth and increased annual billings guide for FY27. With a new AI platform and shift towards being an application and agent company, the company remains well-positioned for continued success. While competitors like DOCS and IQV have their own strengths, Veeva's innovative products and strong customer base make it a top pick for investors seeking exposure to the life sciences industry.
Bears say
Veeva Systems is well-positioned in the life sciences industry due to its best-of-breed offerings, domain expertise, and focus on improving efficiency and compliance. However, the company's recent shift towards AI development and CRM wins may not be enough to offset potential risks such as competitive pressure, macroeconomic challenges, and subscription-based revenue dependence. This makes it a riskier investment, especially given its high valuation compared to its sub-sector, and it may struggle to achieve its low TAM penetration rate of 3%.
This aggregate rating is based on analysts' research of Veeva Systems and is not a guaranteed prediction by Public.com or investment advice.
Veeva Systems (VEEV) Analyst Forecast & Price Prediction
Start investing in Veeva Systems (VEEV)
Order type
Buy in
Order amount
Est. shares
0 shares